A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer
2010 ◽
Vol 116
(6)
◽
pp. 1440-1445
◽
Gabriel N. Hortobagyi
◽
William Heim
◽
Laura Hutchins
◽
Edgardo Rivera
◽
Bernard Mason
◽
...
Gabriel N. Hortobagyi
◽
Robyn R. Young
◽
Mark Karwal
◽
Nuhad K. Ibrahim
◽
Robert Hermann
◽
...
2020 ◽
Vol 20
(3)
◽
pp. 228-237
◽
Noha Rashad
◽
Thoraya Abdelhamid
◽
Samia A. Shouman
◽
Hanan Nassar
◽
Mervat A. Omran
◽
...
H Rugo
◽
S Nanda
◽
A Koustenis
JA García-Sáenz
◽
E Carrasco
◽
ML Kneissl
◽
F Zohren
◽
M Martin
S Tolaney
◽
AQ Lam
◽
S Mukundan
◽
S Nanda
◽
J Cox
◽
...
P Chalasani
◽
AJ Liu
◽
JA Khanjian
◽
M Peha
◽
BJ Buening
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 705-705
N. Gebbia
◽
F. Fulfaro
◽
G. Badalamenti
◽
C. Arcara
◽
G. Cicero
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 564-564
◽
J. T. Carpenter
◽
H. Roché
◽
M. Campone
◽
R. Colomer
◽
A. Jagiello-Gruszfeld
◽
...
2014 ◽
Vol 32
(15_suppl)
◽
pp. 519-519
◽
Joyce O'Shaughnessy
◽
Mario Campone
◽
Etienne Brain
◽
Patrick Neven
◽
Daniel F. Hayes
◽
...
Close
Export Citation Format
Close
Share Document
Close